About Belimumab
            
            Class: | Monoclonal antibody (B-lymphocyte stimulator (BLyS) inhibitor)  
Use: | Treatment of systemic lupus erythematosus (SLE) in adults and pediatric patients aged 5 years and older; treatment of active lupus nephritis in adults  
Adult dose: | Initial dose: 10 mg/kg IV every 2 weeks for the first 3 doses, then 10 mg/kg IV every 4 weeks  
Pediatric dose: | For patients aged 5 years and older: Initial dose: 10 mg/kg IV every 2 weeks for the first 3 doses, then 10 mg/kg IV every 4 weeks (maximu
         
        
            
                
                
                    
                        Drug Class
                    
                    Monoclonal antibody (B-lymphocyte stimulator (BLyS) inhibitor)
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of systemic lupus erythematosus (SLE) in adults and pediatric patients aged 5 years and older; treatment of active lupus nephritis in adults
                 
                
                
                    
                        Storage Requirements
                    
                    Store powder at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light. After reconstitution, use immediately or store at 2°C to 8°C (36°F to 46°F) for up to 8 hours
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Glaxo Group Limited, UNITED KINGDOM
                    
                    
                    Package Size
                    5ml Glass Vial
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 510.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Initial dose: 10 mg/kg IV every 2 weeks for the first 3 doses, then 10 mg/kg IV every 4 weeks
                    
                    
                        Pediatric Dose
                    
                    
                        For patients aged 5 years and older: Initial dose: 10 mg/kg IV every 2 weeks for the first 3 doses, then 10 mg/kg IV every 4 weeks (maximum dose: 120 mg)
                    
                 
                
                
                    
                        Side Effects
                    
                    Nausea, diarrhea, fever, insomnia, headache, infusion reactions, increased risk of infections
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Known hypersensitivity to belimumab or any component of the formulation; active, severe infections
         
        
        
            
                Important Warnings
            
            Increased risk of serious infections; monitor for signs of infection; may cause hypersensitivity reactions; not recommended for use in patients with severe active infections; caution in patients with a history of depression or suicidal thoughts.
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.